Smoking cessation in case of chronic kidney disease;Traitement de l'addiction au tabac au cours des maladies rénales chroniques

Nephrologie et Therapeutique

Volumn 9, Issue 2, 2013, Pages 73-84

  Rostoker, Guy ^a   Le Faou, Anne Laurence ^b   Lagrue, Gilbert ^c  

^a hopital prive Claude Galien   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c NONE   (France)

Author keywords

Bupropion; Chronic kidney disease; Cognitive and comportemental therapies; Smoking cessation; Varenicline

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; FRANCE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; NEPHROLOGIST; PROGNOSIS; SMOKING; SMOKING CESSATION; VASCULAR DISEASE;

EID: 84875891203     PISSN: 17697255     EISSN: 18729177     Source Type: Journal    
DOI: 10.1016/j.nephro.2012.10.008     Document Type: Short Survey

References (63)

1. H.J. Aubin, P. Dupont, and G. Lagrue Comment arrêter de fumer ? 2003 Éditions Odile Jacob Paris
2. J.O. Prochaska, and C.C. DiClemente Stages and processes of self-change of smoking: towards an integrative model of change J Consult Clin Psychol 51 1983 390 395
3. R.J. Perry, W. Griffiths, P. Dextraze, R.J. Solomon, and W.M. Trebbin Elevated nicotine levels in patients undergoing hemodialysis. A role in cardiovascular mortality and morbidity? Am J Med 76 1984 241 246
4. C. Hill, and A. Laplanche Tabagisme et mortalité : aspects épidémiologiques BEH 22-23 2003 98 100
5. K. Wilson, N. Gibson, A. Willan, and D. Cook Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies Arch Intern Med 160 7 2000 939 944
6. N.R. Anthonisen, J.E. Connett, J.P. Kiley, M.D. Altose, W.C. Bailey, and A.S. Buist Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 272 19 1994 1497 1505
7. N.R. Anthonisen, M.A. Skeans, R.A. Wise, J. Manfreda, R.E. Kanner, and J.E. Connett The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial Ann Intern Med 142 4 2005 233 239
8. S. Glantz, and M. Gonzalez Effective tobacco control is key to rapid progress in reduction of non-communicable diseases Lancet 379 2012 1269 1271
9. A. Shankar, R. Klein, and B.E. Klein The association among smoking, heavy drinking and chronic kidney disease AM J Epidemiol 164 2006 263 271
10. M. Tozawa, K. Iseki, C. Iseki, S. Oshiro, Y. Ikemiya, and S. Takishita Influence of smoking and obesity on the development of proteinuria Kidney Int 62 2002 956 962
11. B. Stengel, M.E. Tarver-Carr, N.R. Powe, M.S. Eberhardt, and F.L. Brancati Lifestyle factors, obesity and the risk of chronic kidney disease Epidemiology 14 2003 479 487
12. M. Regalado, S. Yang, and D.E. Wesson Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension Am J Kidney Dis 35 2000 687 694
13. A. Bleyer, L.R. Shemanski, G.L. Burke, K.J. Hansen, and R.G. Appel Tobacco, hypertension and vascular disease: risk factors for renal functionnal decline in an older population Kidney Int 57 2000 2072 2079
14. P.T. Sawicki, U. Didjurgeit, I. Mühlhauser, R. Bender, L. Heinemann, and M. Berger Smoking is associated with progression of diabetic nephropathy Diabetes Care 17 1994 126 131
15. B. Stegmayr, and F. Lithner Tobacco and end stage diabetic nephropathy BMJ 295 1987 581 582
16. S.R. Orth, A. Stöckmann, C. Conradt, and E. Ritz Smoking as a risk factor for end-stage renal failure in men with primary renal disease Kidney Int 54 1998 926 931
17. B. Stengel, C. Couchoud, S. Cénée, and D. Hemon Age, blood pressure and smoking effects on chronic renal failure in primary glomerular disease nephropathies Kidney Int 57 2000 2519 2526
18. R. Yamamoto, Y. Nagasawa, and T. Shoji Cigarette smoking and progression of IgA nephropathy Am J Kidney Dis 56 2010 313 324
19. B. Baggio, A. Budakovic, M. Dalla Vestra, A. Saller, M. Bruseghin, and P. Fioretto Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients J Am Soc Nephrol 13 2002 2730 2736
20. K. Lhotta, H.J. Rumpelt, P. König, G. Mayer, and F. Kronenberg Cigarette smoking and vascular pathology in renal biopsies Kidney Int 61 2002 648 654
21. J.D. Bagdade Accelerated atherosclerosis in patients on maintenance dialysis Adv Nephrol Necker Hosp 9 1980 7 20
22. I.H. Khan, G.R. Catto, N. Edward, and A.M. MacLeod Death during the first 90 days of dialysis: a case control study Am J Kidney Dis 25 1995 276 280
23. R.N. Foley, C.A. Herzog, and A.J. Collins Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study Kidney Int 63 2003 1462 1467
24. G. Pochmalicki, F. Jan, I. Fouchard, E. Teiger, C. Buisson, and A. Benmaadi Fréquence de l'ischémie myocardique indolore au cours de l'hémodialyse de 50 insuffisants rénaux chroniques Arch Mal Cœur 83 1990 1671 1675
25. D.L. Franga, J.M. Kratz, A.J. Crumbley, J.L. Zellner, M.R. Stroud, and F.A. Crawford Early and long-term results of coronary artery bypass grafting in dialysis patients Ann Thorac Surg 70 2000 813 819
26. T. Nakatani, T. Naganuma, J. Uchida, C. Masuda, S. Wada, and T. Sugimura Silent cerebral infarction in hemodialysis patients Am J Nephrol 23 2003 86 90
27. H. Wasse, D.L. Gillen, A.M. Ball, B.R. Kestenbaum, S.L. Seliger, and D. Sherrard Risk factors for upper gastro-intestinal bleeding among end-stage renal disease patients Kidney Int 64 2003 1455 1461
28. F.N. Ozdemir, A. Akcay, A. Bilgic, A. Akgul, Z. Arat, and M. Haberal Effects of smoking and blood eosinophil count on the development of arteriovenous fistulae thrombosis in hemodialysis patients Transplant Proc 37 2005 2918 2921
29. V. Filiopoulos, I. Magelos, N. Tzortzis, and E. Stefanopoulou Smoking and hyperparathyroidism in patients on maintenance hemodialysis BANTAO J 6 2008 34 36
30. N.P. Wang, P.S. Lim, T.T. Chen, L.M. Thien, T.H. Wang, and W.M. Hsu Smoking is associated with alterations of blood thiol-group related antioxydants in patients on hemodialysis Nephron 92 2002 772 779
31. L.S. Malatino, F. Benedetto, F. Mallamaci, G. Tripepi, C. Zoccali on behalf of CREED investigators Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular risk extended evaluation in dialysis patients J Nephrol 12 1999 256 260
32. B.L. Kasiske, and D. Klinger Cigarette smoking in renal transplant recipients J Am Soc Nephrol 11 2000 753 759
33. R.S. Sung, M. Althoen, T.A. Howell, A. Ojo, and R.M. Merion Excess risk of renal allograft loss associated with cigarette smoking Transplantation 71 2001 1752 1757
34. F.G. Cosio, M.E. Falkenhain, and T.E. Pesavento Patient survival after renal transplantation: II impact of cigarette smoking Clin Transplant 13 1999 336 341
35. H. Cardinal, M.J. Hébert, and E. Rhame Modifiable factors predicting patient survival in elderly kidney transplant recipients Kidney Int 68 2005 345 351
36. N. Zitt, B. Kollerits, U. Neyer, W. Mark, D. Heininger, and G. Mayer Cigarette smoking and chronic allograft nephropathy Nephrol Dial Transplant 22 2007 3034 3039
37. C. Maréchal, G. Schlieper, P. Nguyen, T. Krüger, E. Coche, and A. Robert Serum fetiun-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients Clin J Am Soc Nephrol 6 2011 974 985
38. B. Le Foll, P. Melihan-Cheinin, G. Rostoker, Lagrue G Working Group of AFSSAPS Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency Eur Psychiatry 20 5-6 2005 431 441
39. National Institutes of Health State-of-the-Science Conference statement: tobacco use: prevention, cessation, and control Ann Intern Med 145 2006 839 844 http://consensus.nih.gov/2006/tobaccostatement.pdf
40. B. Le Foll, and T.P. George Treatment of tobacco dependence: integrating recent progress into practice CMAJ 177 11 2007 1373 1380
41. G. Rostoker Addiction au tabac. Guide du bon usage du médicament Deuxième édition 2011 Charles Caulin et Gilles Bouvenot, editeurs, Éditions Lavoisier Paris p. 1257-72
42. C. Silagy, T. Lancaster, L. Stead, D. Mant, and G. Fowler Nicotine replacement therapy for smoking cessation Cochrane Database Syst Rev Issue 4 2007
43. G. Lagrue, S. Cormier, and C. Mautrait Les substituts nicotiniques. De la théorie à la pratique Alcool Addictol 27 2 2005 125 130
44. S. Zimmer-Rapuch Tabac et insuffisance rénale (IR) : quels risques et quelles solutions ? La lettre d'ICAR en Néphrologie 2011
45. H.J. Manley, and N.M. Stack Smoking cessation therapy considerations for patients with chronic kidney disease Nephrol Nurs J 35 2008 357 363
46. C.B. Raymond, and H.K. Naylor Smoking cessation in patients with chronic kidney diseases CANNT J 20 2010 24 29
47. K. Cahill, L. Stead, and T. Lancaster A preliminary benefit-risk assessement of varenicline in smoking cessation Drug Saf 32 2 2009 119 135
48. K. Cahill, L.F. Stead, and T. Lancaster Nicotine receptor partial agonists for smoking cessation Cochrane Database Syst Rev Issue 3 2008
49. D.P. Tashkin, S. Rennard, J.T. Hays, W. Ma, D. Lawrence, and T.C. Lee Effects of varenicline on smoking cessation in patients with moderate COPD: a randomized controlled trial Chest 139 2011 591 599
50. N.A. Rigotti, A.L. Pipe, N.L. Benowitz, C. Arteaga, D. Garza, and S. Tonstad Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial Circulation 121 2010 221 229
51. ® : RCP Afssaps-ANSM/EMEA http://www.ema.europa.eu/ docs/en-GB/document-library/EPAR-Product-Information/human/000699/WC500025251. pdf.
52. ® (Varénicline) : bilan à 46 mois.
53. P. Ravva, M.R. Gastonguay, T.G. Tensfeldt, and H.M. Faessel Population pharmakokinetic analysis of varenicline in adult smokers Br J Clin Pharmacol 68 2009 669 681
54. H.M. Faessel, R.S. Scott Obach, H. Rollema, P. Ravva, K.E. Williams, and A. Burstein A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation Clin Pharmacokinet 49 2010 799 816
55. C. Jiménez-Ruiz, I. Berlin, and T. Hering Varenicline: a novel pharmacotherapy for smoking cessation Drugs 69 2009 1319 1338
56. J.R. Hughes, L.F. Stead, and T. Lancaster Antidepressants for smoking cessation Cochrane Database Syst Rev Issue 1 2010
57. ® : RCP Afssaps-ANSM/EMEA http://agence-prd.ansm. sante.fr/php/ecodex/frames.php?specid=64556383&typedoc=R&ref=R0201743. htm.
58. S.P. Worrall, M.K. Almond, and S. Dhillon Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study Nephron Clin Pract 97 2004 c83 c89
59. M.C. Banas, B. Banas, J. Wolf, U. Hoffmann, B. Krüger, and C.A. Böger Smoking behaviour of patients before and after renal transplantation Nephrol Dial Transplant 23 2008 1442 1446
60. N. Lindson, P. Aveyard, and J.R. Hughes Reduction versus abrupt cessation in smokers who want to quit Cochrane Database Syst Rev Issue 3 2010
61. A.L. Le Faou, M. Baha, N. Rodon, G. Lagrue, and J. Ménard Trends in the profile of smokers registered in a national database from 2001 to 2006: changes in smoking habits Public Health 123 1 2009 6 11
62. A.L. Le Faou Quels patients doit-on adresser à l'hôpital pour la prise en charge de leur tabagisme ? Rev Prat 58 3 2008 245 251
63. S.R. Orth, and D.E. Uehlinger Smoking and dialysis: a dreadful scenario for the cardiovascular system? Kidney Int 63 2003 1580 1581